News » Archives » August 2016

Blue-sky Biomedical Projects Launched by New Funding

Author: Arnie Phifer

Innovative research includes efforts to treat Parkinson’s disease, understand heart disease and strokes, tackle bacterial drug resistance

Advanced Diagnostics & Therapeutics (AD&T), a strategic research initiative at the University of Notre Dame, has announced the recipients of its Discovery Fund awards for 2016. Each year, these awards are given to scientists and engineers who propose novel technologies that can improve human and environmental health. “We fund researchers who have exciting, sometimes risky ideas but need assistance to kick-start their investigations and collect preliminary data,” explained Paul Bohn, AD&T’s director. “There’s also a focus on selecting projects that have a recognizable path to becoming high-impact, marketable products.”

Read More

Quinn family provides $5 million gift for Phase II of Innovation Park

Author: Dennis Brown

The late Thomas Quinn and his wife, Diane, have made a $5 million gift to the University of Notre Dame for the construction of the second phase of Innovation Park.

The Thomas H. and Diane G. Quinn Hall for Innovation and Change will be a 40,000-square-foot, three-level facility located on a 12-acre site immediately south of the Notre Dame campus on Angela Boulevard. Construction is expected to begin late this fall or early winter.

Read More

Video: Magnetoelectric nanoparticles for targeted drug delivery in cancer treatment

Author: Heidi Deethardt

A team of Notre Dame researchers from NDnano, AD&T, and Harper Cancer Research Institute have started to investigate the use of magnetoelectric nanoparticles (MENs) as carrier vehicles for targeted drug delivery in cancer treatment. 

The MENs work, led by Dr. Tiffanie Stewart, builds on research published this year by her alma mater, Florida International University (Scientific Reports, 6:20867, DOI: 101038/srep20867

Read More